BARNES ALANE P (Senior VP, Chief Legal Officer) sold 13.5% of their position (62.50K shares) of BIOCRYST PHARMACEUTICALS INC on the open market
Open‑market sale worth $596.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/15/2026ACC: 0000882796-26-000021
Officer· Senior VP, Chief Legal Officer
Since Nov 2018
-62.50K
Net shares
Net seller
$596.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
62.50K acquired · 125K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+62.50K
Price / share
$5.04
Trade value
$315K
% of position
15.6%
5/13/2026
400.70K→463.20K
Common Stock
Direct
Shares
−62.50K
Price / share
$9.54
Trade value
$596.25K
% of position
13.5%
5/13/2026
463.20K→400.70K
Total
Net shares
+0.00
Net value
-$281.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | M · Option Exercise | +62.50K | $5.04 | $315K | 15.6% | 400.70K | 463.20K |
| Common Stock Direct | 5/13/2026 | S · Sale | −62.50K | $9.54 | $596.25K | 13.5% | 463.20K | 400.70K |
| Total | +0.00 | -$281.25K | ||||||
Derivative Transactions1
Emp. Stock Option (Right to Buy)
Direct
Converts to
Common Stock
62.50K shares
Shares
−62.50K
Strike price
5.04
Held after
0.00
Exercisable
—
5/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Emp. Stock Option (Right to Buy) Direct | Common Stock62.50K shares | 5/13/2026 | M · Option Exercise | −62.50K | 5.04 | — | 0.00 |